Evidence map›Paper›PMID 40666594›Full record

ArticleCureus2025

Paraneoplastic Amyopathic Dermatomyositis Associated With a Bone and Medullary Location of Breast Adenocarcinoma.

Fadwa Haboub, Mohamed El Fadli, Othmane Zouiten, Leila Afani, Rhizlane Belbaraka

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Multidimensional roles and clinical significance of GATA3 in breast cancer.Frontiers in cell and developmental biology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fadwa HaboubDepartment of Medical Oncology, Centre Hospitalo-Universitaire Mohammed VI, Marrakesh, MAR.
Mohamed El FadliDepartment of Medical Oncology, Cadi Ayyad University, Marrakesh, MAR.
Othmane ZouitenDepartment of Medical Oncology, Centre Hospitalo-Universitaire Mohammed VI, Marrakesh, MAR.
Leila AfaniDepartment of Medical Oncology, Centre Hospitalo-Universitaire Mohammed VI, Marrakesh, MAR.
Rhizlane BelbarakaDepartment of Medical Oncology, Centre Hospitalo-Universitaire Mohammed VI, Marrakesh, MAR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Paraneoplastic amyopathic dermatomyositis (ADM) is a rare connective tissue disease presenting with characteristic dermatomyositis-like skin findings in the absence of muscle involvement. It is associated with malignancies in 15%-30% of cases and may portend a fatal outcome, especially when linked to advanced cancers. We report the case of a 58-year-old woman who presented with progressive low back pain and erythroderma. Imaging revealed diffuse bone metastases, and bone biopsy confirmed a poorly differentiated adenocarcinoma of breast origin (estrogen receptor, 60%; progesterone receptor, 35%; GATA3 positive). Simultaneously, dermatological evaluation identified periungual erythema and other cutaneous findings consistent with ADM. The patient was started on endocrine therapy with palbociclib and letrozole, along with corticosteroids and hydroxychloroquine, resulting in partial clinical improvement. However, within six months of diagnosis, she developed severe COVID-19 pneumonia, complicated by pancytopenia and sepsis, and ultimately succumbed to multiorgan failure despite intensive care support. This case underlines the importance of recognizing paraneoplastic ADM as an initial manifestation of malignancy. A multidisciplinary approach is key, but the prognosis largely depends on the cancer's burden and complications such as treatment-induced immunosuppression.

Indexed as

breast cancercdk4/6 inhibitorserythrodermamedullary locationparaneoplastic amyopathic dermatomyositis

Identifiers

PMID40666594
PMCPMC12260473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.